This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will evaluate the safety and toxicity of the colony stimulating factor GM-CSF (granulocyte-macrophage colony stimulating factor) in people who have pain in their legs while walking because of blockages in the arteries of their legs. Some individuals are able to naturally grow new blood vessels in an attempt to form bypasses around the blockages. Often these new vessels are inadequate to supply sufficient blood. If it can be safely used, GM-CSF will be used to stimulate new blood vessel growth and relieve symptoms.
Showing the most recent 10 out of 675 publications